Vimarsana
Biggest News Aggregation in the World

Page 13 - Antipsychotics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antipsychotics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antipsychotics Today - Breaking & Trending Today

Hiccups in Patients With Cancer Often Overlooked, Undertreated - Vimarsana News

Hiccups in Patients With Cancer Often Overlooked, Undertreated

Persistent hiccups can impact a patient's quality of life when not adequately treated, according to a survey of cancer care clinicians.

FDA Puts REMS Requirements on Hold to Ensure Continuity of Care - Vimarsana News

FDA Puts REMS Requirements on Hold to Ensure Continuity of Care

The FDA will temporarily not enforce certain clozapine REMS program requirements to ensure continuity of care for patients taking the antipsychotic.

Antipsychotic Trials Show Increasing Placebo Response and Declining Drug Response - Vimarsana News

Antipsychotic Trials Show Increasing Placebo Response and Declining Drug Response

A new review of antipsychotic trials finds that the placebo response rate is steadily increasing and drug response is decreasing.

Menopause an Independent Risk Factor for Schizophrenia Relapse? - Vimarsana News

Menopause an Independent Risk Factor for Schizophrenia Relapse?

Antipsychotics become less effective as estrogen levels drop, making women with schizophrenia more vulnerable to relapse as they age, new research shows.

'Amazing' Phase 3 Results for Novel Schizophrenia Combo Drug - Vimarsana News

'Amazing' Phase 3 Results for Novel Schizophrenia Combo Drug

A novel agent that combines xanomeline and trospium (KarXT) provides clinically meaningful benefits in schizophrenia, new results from the phase 3 EMERGENT-2 trial suggest.